Victoria Klepsch

11PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targetsRespiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 27, 2026
NR2F6 deletion revives CAR-T cell function and induces antigen-agnostic immune memory in solid tumors.

Dominik Humer, Victoria Klepsch, Dietmar Rieder

|Nov 27, 2025
Inhibition of PKCθ Abrogates CD8+ T Cell-Mediated Neurotoxicity in Murine Cerebral Malaria.

Karin Albrecht-Schgör, Victoria E Stefan, Martina Steinlechner

|Aug 13, 2025
NR2F6 as a Disease Driver and Candidate Therapeutic Target in Experimental Cerebral Malaria.

Victoria E Stefan, Victoria Klepsch, Nikolaus Thuille

|Jun 24, 2025
Potentiation of cancer immunogenicity by targeting PARP.

Dominik Humer, Victoria Klepsch, Gottfried Baier

|Jul 10, 2024
A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection.

Miriam Bosch, Nina Kallin, Sainitin Donakonda

|Jul 05, 2023
Melanoma-intrinsic NR2F6 activity regulates antitumor immunity.

Hyungsoo Kim, Yongmei Feng, Rabi Murad

Pageof 2